Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Hazra

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|April 21, 2020
Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfectedClaudia S Crowell, Paige L Williams, Cenk Yildirim, et al.
American Journal of Epidemiology|July 25, 2022
Analyzing Longitudinally Collected Viral Load Measurements in Youth With Perinatally Acquired HIV Infection: Problems and Possible RemediesSean S Brummel, Russell B Van Dyke, Kunjal Patel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir ExposureSarah K Himes, Yanling Huo, George K Siberry, et al.
Nutrition Research (New York, N.Y.)|November 18, 2009
Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin EJacqueline P Monteiro, Laura Freimanis-Hance, Lidiane B Faria, et al.
AIDS Research and Human Retroviruses|November 10, 2015
Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United StatesBrian Kirmse, Tzy-Jyun Yao, Sean Hofherr, et al.
AIDS (London, England)|March 31, 2017
Delay in sexual maturation in perinatally HIV-infected youths is mediated by poor growthAndrea Bellavia, Paige L Williams, Linda A DiMeglio, et al.
AIDS (London, England)|July 17, 2015
CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United StatesLee Fairlie, Brad Karalius, Kunjal Patel, et al.
AIDS (London, England)|January 6, 2016
Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based designPaige L Williams, Rohan Hazra, Russell B Van Dyke, et al.
The Pediatric Infectious Disease Journal|May 18, 2016
Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young AdultsMarc Foca, Ram Yogev, Andrew Wiznia, et al.
AIDS (London, England)|June 12, 2010
Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youthSuad Kapetanovic, Erin Leister, Sharon Nichols, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|April 21, 2020
Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfectedClaudia S Crowell, Paige L Williams, Cenk Yildirim, et al.
American Journal of Epidemiology|July 25, 2022
Analyzing Longitudinally Collected Viral Load Measurements in Youth With Perinatally Acquired HIV Infection: Problems and Possible RemediesSean S Brummel, Russell B Van Dyke, Kunjal Patel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir ExposureSarah K Himes, Yanling Huo, George K Siberry, et al.
Nutrition Research (New York, N.Y.)|November 18, 2009
Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin EJacqueline P Monteiro, Laura Freimanis-Hance, Lidiane B Faria, et al.
AIDS Research and Human Retroviruses|November 10, 2015
Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United StatesBrian Kirmse, Tzy-Jyun Yao, Sean Hofherr, et al.
AIDS (London, England)|March 31, 2017
Delay in sexual maturation in perinatally HIV-infected youths is mediated by poor growthAndrea Bellavia, Paige L Williams, Linda A DiMeglio, et al.
AIDS (London, England)|July 17, 2015
CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United StatesLee Fairlie, Brad Karalius, Kunjal Patel, et al.
AIDS (London, England)|January 6, 2016
Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based designPaige L Williams, Rohan Hazra, Russell B Van Dyke, et al.
The Pediatric Infectious Disease Journal|May 18, 2016
Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young AdultsMarc Foca, Ram Yogev, Andrew Wiznia, et al.
AIDS (London, England)|June 12, 2010
Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youthSuad Kapetanovic, Erin Leister, Sharon Nichols, et al.
Pageof 15